Sign inJoin waitlistJoin the waitlist

Christina Washington

Asst. Professor, Obstetrics & Gynecology · University of Oklahoma College of Medicine

Credentials: · · · · · ·

History

University of Oklahoma College of Medicine
Present
University of Oklahoma College of Medicine
Present

Gynecologic Oncology
University of Oklahoma Health Sciences Center
2018–2021
Obstetrics and Gynecology
OB/GYN Pennsylvania Hospital
2014–2018
Rutgers, Robert Wood Johnson Medical School
2008–2012

Research

TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomes
Gynecologic Oncology · 2023 · 35 citations
Effectiveness of PARP Inhibitor Maintenance Therapy in Ovarian Cancer by BRCA1/2 and a Scar-Based HRD Signature in Real-World Practice
Clinical Cancer Research · 2024 · 26 citations
PARP inhibitors in the treatment of ovarian cancer: a review
Review · Current Opinion in Obstetrics & Gynecology · 2021 · First of 2 authors · 22 citations

Kathleen Moore
15 papers
Bhavana Pothuri
7 papers
Amanda Jackson
6 papers
Emily Ko
6 papers · 4 as a resident
Angeles Secord
5 papers
Bradley Corr
5 papers
GM
George Maxwell
5 papers
Gottfried Konecny
5 papers
Jason Wright
5 papers
Premal Thaker
5 papers
Rebecca Arend
5 papers
Tara Castellano
5 papers · 2 as a fellow

Clinical trials

Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)
Principal investigator · Active not recruiting · Phase 2
University of Oklahoma
2024–2029
A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib
Principal investigator · Recruiting · Phase 2
University of Oklahoma
2023–2029
Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer
Principal investigator · Active not recruiting · Phase 1
University of Oklahoma
2020–2027
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2028